PYRAZOLYLPHENYL AND PYRROLYLPHENYL INHIBITORS OF LTA4H FOR TREATING INFLAMMATION
    6.
    发明申请
    PYRAZOLYLPHENYL AND PYRROLYLPHENYL INHIBITORS OF LTA4H FOR TREATING INFLAMMATION 失效
    LTA4H用于治疗炎症的吡咯并噻吩和吡咯烷酮抑制剂

    公开(公告)号:US20080033013A1

    公开(公告)日:2008-02-07

    申请号:US11833313

    申请日:2007-08-03

    摘要: Two chemical genera of pyrazolylphenyl and pyrrolylphenyl derivatives are disclosed. They have the general formula: In these compounds ring (a) is a pyrazole or pyrrole; Q is selected from the group consisting of a direct bond, O, S, SO, SO2, NR1, CH2, CF2, and C(O); HET is a 4-7-membered saturated nitrogenous heterocycle; and taken together ZW is H or Z is (CH2)1-10 in which one or two (CH2) may optionally be replaced by —O—, —NR1—, —SO—, —S(O)2—, —C(═O)— or —C═O(NH)—; and W is hydrogen, acyl, hydroxyl, carboxyl, amino, carboxamido, aminoacyl, —COOalkyl, —CHO, heterocyclyl, substituted aryl or substituted heterocyclyl. The compounds are inhibitors of LTA4H (leukotriene A4 hydrolase). They are useful for the treatment and prevention and prophylaxis of inflammatory diseases and disorders.

    摘要翻译: 公开了吡唑基苯基和吡咯基苯基衍生物的两种化学属。 它们具有以下通式:在这些化合物中,环(a)是吡唑或吡咯; Q选自直接键O,S,SO,SO 2,NR 1,CH 2,CF 3, SUB 2和C(O); HET是4-7元饱和含氮杂环; 并且合并在一起ZW是H或Z是(CH 2)2 - ,其中一个或两个(CH 2/2)可以任选地被替换 ,-O - , - SO - , - S(O)2 - , - C( - ) - 或-CO(NH) - ; W是氢,酰基,羟基,羧基,氨基,甲酰胺基,氨基酰基,-COO烷基,-CHO,杂环基,取代的芳基或取代的杂环基。 这些化合物是LTA4H(白三烯A4水解酶)的抑制剂。 它们可用于治疗和预防和预防炎性疾病和病症。

    Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation
    7.
    发明授权
    Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation 失效
    吡唑基苯基和LTA4H的吡咯基苯基抑制剂用于治疗炎症

    公开(公告)号:US08115005B2

    公开(公告)日:2012-02-14

    申请号:US11833313

    申请日:2007-08-03

    IPC分类号: C07D401/00 A61K31/445

    摘要: Two chemical genera of pyrazolylphenyl and pyrrolylphenyl derivatives are disclosed. They have the general formula: In these compounds ring (a) is a pyrazole or pyrrole; Q is selected from the group consisting of a direct bond, O, S, SO, SO2, NR1, CH2, CF2, and C(O); HET is a 4-7-membered saturated nitrogenous heterocycle; and taken together ZW is H or Z is (CH2)1-10 in which one or two (CH2) may optionally be replaced by —O—, —NR1—, —SO—, —S(O)2—, —C(═O)— or —C═O(NH)—; and W is hydrogen, acyl, hydroxyl, carboxyl, amino, carboxamido, aminoacyl, —COOalkyl, —CHO, heterocyclyl, substituted aryl or substituted heterocyclyl. The compounds are inhibitors of LTA4H (leukotriene A4 hydrolase). They are useful for the treatment and prevention and prophylaxis of inflammatory diseases and disorders.

    摘要翻译: 公开了吡唑基苯基和吡咯基苯基衍生物的两种化学属。 它们具有以下通式:在这些化合物中,环(a)是吡唑或吡咯; Q选自直接键O,S,SO,SO2,NR1,CH2,CF2和C(O); HET是4-7元饱和含氮杂环; 并且一起ZW是H或Z是(CH 2)1-10,其中一个或两个(CH 2)可以任选地被-O-,-NR1-,-SO-,-S(O)2 - , - C (= O) - 或-C = O(NH) - ; W是氢,酰基,羟基,羧基,氨基,甲酰胺基,氨基酰基,-COO烷基,-CHO,杂环基,取代的芳基或取代的杂环基。 这些化合物是LTA4H(白三烯A4水解酶)的抑制剂。 它们可用于治疗和预防和预防炎性疾病和病症。